Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 4OTHER_GOV 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Head & Neck 1Gynecologic 1Gastrointestinal 1Endocrine 1Dermatologic 1Breast 1

Conditions

Neuroendocrine Tumors 14Thyroid Cancer, Papillary 12Thyroid Neoplasms 7Pheochromocytoma 5Paraganglioma 5Thyroid Nodule 2Pituitary Neoplasms 2Multiple Endocrine Neoplasia Type 1 2Lymphatic Metastasis 2Adrenal Gland Neoplasms 2Wounds and Injuries 1Vocal Cord Paralysis 1Thyroid Diseases 1Thyroid Carcinoma, Anaplastic 1Thymoma 1Teratoma 1Sarcoma 1Recurrence 1Pituitary Diseases 1Parkinson Disease 1Neuroblastoma 1Neoplasms 1Mesothelioma 1Lung Neoplasms 1Hypersensitivity 1Growth Hormone-Secreting Pituitary Adenoma 1Goiter 1Gastro-enteropancreatic neuroendocrine tumor 1Euthyroid Goiter 1Disease 1

Interventions

Tomography, Emission-Computed, Single-Photon 1Iodine-124 1Iodine-123 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Parkinson Disease × Endocrine × Clear all
NCT01931488 2013-08-29

124I-MIBG Tracer Evaluation of Myocardial Sympathetic Denervation and Assessment of Neuroendocrine Tumors.

Tel-Aviv Sourasky Medical Center

Phase 2 Unknown
40 enrolled
EndocrineNET

Parkinson Disease, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡